Welcome to our dedicated page for PTQQD news (Ticker: PTQQD), a resource for investors and traders seeking the latest updates and insights on PTQQD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PTQQD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PTQQD's position in the market.
Quipt Home Medical Corp. has expanded its national footprint by acquiring three entities across California, Missouri, Arkansas, and Mississippi.
These acquisitions are expected to generate approximately $5.5 million in annualized revenues and an Adjusted EBITDA margin of 10% prior to integration.
With the addition of over 10,000 active patients and six locations, Quipt aims to leverage existing infrastructure for enhanced growth and efficiency.
Quipt Home Medical Corp. has successfully exercised common share purchase warrants, generating proceeds of $17.5 million over the past 12 months. The company issued 3,389,825 common shares at a price of CAD$6.40 each, with the vast majority issued since April 2021. Following this issuance, Quipt's total common shares outstanding stands at 33,102,529. CEO Greg Crawford views the warrant exercises as a strong vote of confidence from shareholders, expressing optimism about the company's acquisition plans and its future growth in the durable medical equipment sector.
Quipt Home Medical Corp. (NASDAQ:QIPT; TSXV:QIPT) announced a webcasted presentation on June 24, 2021, during the Sidoti Virtual Investor Conference.
The live event will commence at 9:15 AM ET, aimed at sharing the company's growth story and plans to expand its shareholder base following its Nasdaq listing. CEO Greg Crawford expressed optimism about their acquisition pipeline and the potential for strong growth in the second half of the year.
Quipt provides in-home monitoring and chronic disease management services, primarily focusing on respiratory care.
Quipt Home Medical Corp. reported a 36% revenue increase in Q2 2021, totaling $24.2 million compared to $17.9 million in Q2 2020. The company achieved 13% organic growth year-to-date, with recurring revenue exceeding 75% of total revenue. Adjusted EBITDA rose 28% year-over-year to $5.4 million. Noteworthy operational metrics include a 155% increase in respiratory resupply setups. Following a successful NASDAQ listing and recent expansion efforts, including new locations in Daytona Beach and Concord, Quipt is well-positioned for future growth.
Quipt Home Medical Corp. began trading on the Nasdaq Capital Market under the symbol QIPT as of May 27, 2021, while continuing its listing on the TSX Venture Exchange. The company, which focuses on home medical equipment and respiratory care, operates across 51 locations in 11 states, serving over 120,000 active patients. CEO Greg Crawford emphasized that this listing enhances global visibility and liquidity for investors. Additionally, Quipt plans to hold a Q2 earnings conference call on June 1, 2021, at 10:00 a.m. (EST).
Quipt Home Medical Corp. (TSXV:QIPT; OTCQX:PTQQD) announced its common shares will begin trading on the Nasdaq Capital Market under the ticker symbol 'QIPT' on May 27, 2021. This listing marks a significant achievement for the Company, reflecting its growth and evolution as a publicly traded entity. CEO Greg Crawford highlighted that the Nasdaq listing will enhance liquidity and expand the shareholder base. Quipt specializes in in-home monitoring and disease management services, focusing on respiratory care and chronic health conditions.
Quipt Home Medical Corp. (TSXV:QIPT; OTCQX:PTQQD) announced it will host its Q2 Fiscal 2021 earnings conference call on June 1, 2021, at 10:00 a.m. EDT. The call will include a discussion of its financial results, emphasizing its focus on providing in-home monitoring and chronic disease management services. The company aims to enhance shareholder value by expanding its service offerings, particularly for patients with chronic health conditions. Investors can join via toll-free numbers or listen to the audio webcast available on Quipt's investor website.
Quipt Home Medical Corp. announced the filing of a Form 40-F Registration Statement with the SEC, marking a critical step towards its listing on NASDAQ. This achievement allows Quipt to become a reporting issuer in the U.S. alongside Canada. The company aims to enhance its visibility in the U.S. market for respiratory homecare and has expressed optimism about leveraging its strong balance sheet and operational momentum. Approval from NASDAQ for the listing is still pending, contingent on all regulatory requirements being met.
Quipt Home Medical Corp. (OTCQX: PTQQD) announced the consolidation of its common shares on a 1-for-4 basis, effective May 13, 2021. This move reduces the total shares from over 122 million to approximately 30.6 million, aiming to meet the Nasdaq minimum share price requirement for a future listing. The shares will trade on OTCQX under symbol PTQQD for 20 business days before changing to PTQQF, then to QIPT post-Nasdaq listing. Additionally, the conversion price of its unsecured convertible debentures has been adjusted to $5.20 per share.
